US Patent Issued to NEW YORK MEDICAL COLLEGE on July 15 for "Use of rifaximin on circulating aged neutrophils in sickle cell disease" (New York Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,620, issued on July 15, was assigned to NEW YORK MEDICAL COLLEGE (Valhalla, N.Y.).

"Use of rifaximin on circulating aged neutrophils in sickle cell disease" was invented by Seah H. Lim (Hawthorne, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treatment of sickle cell disease are based on the administration of the antibiotic compound rifaximin."

The patent was filed on March 23, 2020, under Application No. 17/441,840.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=...